Sotalol hydrochloride 5 MG/ML Oral Solution — RxCUI 1593725
RxNorm drug concept · Semantic clinical drug
RxCUI 1593725
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1593725
Official nameSotalol hydrochloride 5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assotalol HCl 5 MG per 1 ML Oral Solution; sotalol HCl 5 MG in 1 mL Oral Solution
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)2,392 prescriptions · 20 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sotalol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sotalol treats life-threatening ventricular arrhythmias. Some products also help keep a normal rhythm in people with highly symptomatic atrial fibrillation or flutter. It has not b...
- Sotalol can cause dangerous rhythm problems, especially in the first days or after a dose increase. In the hospital your heart is monitored continuously and your kidney function is...
- Why do I have to start it in the hospital?
- No. Stopping suddenly can cause chest pain or even a heart attack, especially if you have heart disease. If you need to stop, your doctor will usually lower the dose over 1 to 2 we...
🕸️ Concept Web — How Sotalol hydrochloride 5 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Sotalol hydrochloride 5 MG/ML Oral Solution
RxCUI 1593725 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Sotalol
9947IN -
Sotalol hydrochloride
7008PIN
-
Sotalol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Sotylize
1593726BN
-
Sotylize
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Sotalol Oral Solution
1593724SCDF -
Sotalol hydrochloride Oral Solution
2648285SCDFP -
Sotalol Oral Liquid Product
1593723SCDG -
Sotalol Oral Product
1161104SCDG -
Sotalol hydrochloride Oral Liquid Product
2662856SCDGP -
Sotalol hydrochloride Oral Product
2659339SCDGP -
Sotalol Oral Solution [Sotylize]
1593728SBDF -
Sotalol hydrochloride Oral Solution [Sotylize]
2654819SBDFP - +5 more in this family
-
Sotalol Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Sotalol hydrochloride 5 MG/ML
1593722SCDC -
Sotalol hydrochloride 5 MG/ML Oral Solution [Sotylize]
1593731SBD -
Sotalol hydrochloride 5 MG/ML [Sotylize]
1593727SBDC
-
Sotalol hydrochloride 5 MG/ML
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Sotalol hydrochloride 5 MG/ML
SCDC · 1593722 -
Sotalol Oral Solution
SCDF · 1593724 -
Sotalol hydrochloride Oral Solution
SCDFP · 2648285 -
Sotalol Oral Liquid Product
SCDG · 1593723 -
Sotalol Oral Product
SCDG · 1161104 -
Sotalol hydrochloride Oral Liquid Product
SCDGP · 2662856 -
Sotalol hydrochloride Oral Product
SCDGP · 2659339
Brand-Name Concepts
-
Sotalol hydrochloride 5 MG/ML Oral Solution [Sotylize]
SBD · 1593731 -
Sotalol hydrochloride 5 MG/ML [Sotylize]
SBDC · 1593727 -
Sotalol Oral Solution [Sotylize]
SBDF · 1593728 -
Sotalol hydrochloride Oral Solution [Sotylize]
SBDFP · 2654819 -
Sotylize Oral Liquid Product
SBDG · 1593729 -
Sotylize Oral Product
SBDG · 1593730 -
Sotylize
BN · 1593726
📦 FDA Products & Package NDCs
1 product · 2 package NDCs
2 package NDCs map to RxCUI 1593725 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 24338-0530-25 | 250 mL in 1 BOTTLE (24338-530-25) | SOTYLIZE | Azurity Pharmaceuticals, Inc. | 2015-03-01 |
| 24338-0530-48 | 480 mL in 1 BOTTLE (24338-530-48) | SOTYLIZE | Azurity Pharmaceuticals, Inc. | 2015-03-01 |
Observed labelers:
Azurity Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$2.3259
Range $2.3166–$2.3353
· middle 50% $2.3212–$2.3306
· 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.